Value-Based Insurance Design


In order to combat a projected budget gap of $3.8 billion, Connecticut state employees were provided the opportunity to enroll in a program using value-based insurance benefit design concepts.
CMS has announced its plans to evaluate a new value-based payment model for prescription drugs covered under the Part B program. This is yet another move by the federal body to ensure quality care for Medicare enrollees.
The American Journal of Managed Care's co-editor-in-chief A. Mark Fendrick, MD, director of the University of Michigan Center for Value-Based Insurance Design (VBID), is testifying on how the principles of VBID and clinical nuance can contribute to healthcare reform in the US military health system.
Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.
Patrick Conway, MD, explains why CMS looked toward value-based insurance design for Medicare Advantage plans.


April 6th to 11th, 2014
Bedford, MA
July 3rd to 5th, 2014
Orlando, FL
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium